Baicheng Pharma Suspends Shares Amid Planned Control Transfer on May 26

GateNews
According to an announcement on May 26, Baicheng Pharma disclosed that its controlling shareholders are planning a material transaction involving a change of control. The company's shares will remain suspended from trading on May 27 (Wednesday) and are expected to remain halted for no more than three trading days, pending Shenzhen Stock Exchange approval.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments